All News
-- particles
Showing 1 to 25 of 75
News > 07-May-2024
WILLIAM & MARY | RAYMOND A. MASON SCHOOL OF BUSINESS EMBA COHORT VISITS EYRIS
News > 24-Apr-2024
SELENA+ ADOPTED AS FIRST MEDICAL AI IN BRUNEI DARUSSALAM
News > 21-Apr-2024
SELENA+ IN ACTION DURING DIABETES MALAYSIA AGM
News > 15-Apr-2024
EyRIS PARTICIPATES IN DIABETIC RETINOPATHY SCREENING INITIATIVE IN MONGOLIA
News > 28-Mar-2024
EyRIS FOUNDER NAMED ON ASIA WOMEN TECH LEADERS (AWTL) AWARD LIST
News > 02-Feb-2024
PLINY & EyRIS JOIN HANDS TO ENSURE INTEROPERABILITY
News > 29-Jan-2024
EyRIS CONGRATULATES FOUNDER ON APPOINTMENT TO NEJM AI EDITORIAL BOARD
News > 23-Jan-2024
EYRIS ANNOUNCES COLLABORATION WITH ICARE
News > 22-Jan-2024
EYRIS APPOINTS PARTNER IN UAE
News > 08-Jan-2024
EYRIS SELENA+ ATTAINS EU MEDICAL DEVICE REGULATION COMPLIANCE
News > 16-Dec-2023
EyRIS ANNOUNCES PARTNERSHIP WITH ADVANCE INNOVATION IN MYANMAR
News > 12-Dec-2023
EyRIS SECURES NATIONAL SCREENING PROJECT IN SULTANATE OF OMAN
News > 29-Nov-2023
SELENA+ USED AS TEACHING CASE FOR BUSINESS STUDENTS & CORPORATES WORLDWIDE
News > 16-Oct-2023
EyRIS APPOINTS PARTNER IN MYANMAR
News > 15-Oct-2023
EyRIS ANNOUNCES PARTNERSHIP IN QATAR
News > 21-Aug-2023
EyRIS SELENA+ Approved For Use In Australia
News > 07-Jun-2023
EyRIS Forms Tri-Partite Partnership To Bring SELENA+ To Tanzania
News > 05-Jun-2023
Sao Rafael Hospital, Brazil Powers Screening Using AI Technology
News > 02-Jun-2023
SELENA+ In Another Community Outreach Program
News > 01-Jun-2023
EyRIS And Optometrist Warehouse To Advance Healthcare With AI-Driven Diabetic Retinopathy Screening
News > 31-May-2023
SELENA+ Receives Regulatory Approval From Ministry Of Health & Prevention, UAE
News > 31-May-2023
EyRIS Signs Partnership With VUNO
News > 04-May-2023
SELENA+ Journey Featured Physician Scientist Summit In Jordan
News > 01-Feb-2023
EyRIS Showcases Latest Innovations In Arab Health 2023
News > 04-Nov-2022
EyRIS Wins The Frontiers Award In The AsiaStar 10×10 Campaign
Showing 1 to 25 of 75